Manufacturer of Controlled Substances; Notice of Registration, 9615 [2010-4403]
Download as PDF
Federal Register / Vol. 75, No. 41 / Wednesday, March 3, 2010 / Notices
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated October 16, 2009, and
published in the Federal Register on
October 28, 2009, (74 FR 55587),
American Radiolabeled Chemical, Inc.,
101 Arc Drive, St. Louis, Missouri
63146, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
schedules I and II:
Drug
mstockstill on DSKH9S0YB1PROD with NOTICES
[FR Doc. 2010–4403 Filed 3–2–10; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
small quantities of the listed controlled
substances as radiolabeled compounds
for biochemical research.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
American Radiolabeled Chemical, Inc.
to manufacture the listed basic classes
of controlled substances is consistent
with the public interest at this time.
DEA has investigated American
Radiolabeled Chemical Inc. to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
16:08 Mar 02, 2010
Dated: February 24, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Schedule
Gamma
Hydroxybutyric
Acid
(2010) ........................................
Ibogaine (7260) ............................
Lysergic acid diethylamide (7315)
Tetrahydrocannabinols (7370) ......
Dimethyltryptamine (7435) ...........
1-[1-(2–
Thienyl)cyclohexyl]piperidine
(7470) ........................................
Dihydromorphine (9145) ...............
Normorphine (9313) .....................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Amobarbital (2125) .......................
Phencyclidine (7471) ....................
Phenylacetone (8501) ..................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Ecgonine (9180) ...........................
Hydrocodone (9193) .....................
Meperidine (9230) ........................
Metazocine (9240) ........................
Dextropropoxyphene, bulk (nondosage forms) (9273) ...............
Morphine (9300) ...........................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ....................
Phenazocine (9715) .....................
Fentanyl (9801) ............................
VerDate Nov<24>2008
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Jkt 220001
Drug Enforcement Administration
Manufacturer of Controlled
Substances Notice of Registration
By Notice dated October 21, 2009, and
published in the Federal Register on
October 28, 2009, (74 FR 55588),
Johnson Matthey Inc., Custom
Pharmaceuticals Department, 2003
Nolte Drive, West Deptford, New Jersey
08066–1742, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
schedules I and II:
Drug
Frm 00044
Fmt 4703
The company plans to manufacture
the listed controlled substances in bulk
for sale to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Johnson Matthey Inc. to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Johnson Matthey Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: February 24, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–4404 Filed 3–2–10; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Office of the Secretary
Schedule
Gamma
Hydroxybutyric
Acid
(2010) ........................................
Tetrahydrocannabinols (7370) ......
Dihydromorphine (9145) ...............
Difenoxin (9168) ...........................
Propiram (9649) ............................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Lisdexamfetamine (1205) .............
Methylphenidate (1724) ................
Nabilone (7379) ............................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Ecgonine (9180) ...........................
Hydrocodone (9193) .....................
Meperidine (9230) ........................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Morphine (9300) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ....................
Noroxymorphone (9668) ...............
Alfentanil (9737) ...........................
Remifentanil (9739) ......................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
PO 00000
9615
Sfmt 4703
Bureau of International Labor Affairs:
Labor Advisory Committee for Trade
I Negotiations and Trade Policy
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
ACTION:
Meeting Notice.
SUMMARY: Pursuant to the provisions of
the Federal Advisory Committee Act
(Pub. L. 92–463, as amended), notice is
hereby given of a meeting of the Labor
Advisory Committee for Trade
Negotiation and Trade Policy.
Date, Time, Place: March 16, 2010;
10:30 a.m.–11:30 a.m.; U.S. Department
of Labor, Secretary’s Conference Room,
200 Constitution Ave., NW.,
Washington, DC.
Purpose: The meeting will include a
review and discussion of current issues
which influence U.S. trade policy.
Potential U.S. negotiating objectives and
bargaining positions in current and
anticipated trade negotiations will be
discussed. Pursuant to 19 U.S.C. 2155(f)
it has been determined that the meeting
will be concerned with matters the
disclosure of which would seriously
compromise the Government’s
negotiating objectives or bargaining
E:\FR\FM\03MRN1.SGM
03MRN1
Agencies
[Federal Register Volume 75, Number 41 (Wednesday, March 3, 2010)]
[Notices]
[Page 9615]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-4403]
[[Page 9615]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated October 16, 2009, and published in the Federal
Register on October 28, 2009, (74 FR 55587), American Radiolabeled
Chemical, Inc., 101 Arc Drive, St. Louis, Missouri 63146, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the basic classes of controlled
substances listed in schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)............................. I
Ibogaine (7260).............................................. I
Lysergic acid diethylamide (7315)............................ I
Tetrahydrocannabinols (7370)................................. I
Dimethyltryptamine (7435).................................... I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470)................. I
Dihydromorphine (9145)....................................... I
Normorphine (9313)........................................... I
Amphetamine (1100)........................................... II
Methamphetamine (1105)....................................... II
Amobarbital (2125)........................................... II
Phencyclidine (7471)......................................... II
Phenylacetone (8501)......................................... II
Cocaine (9041)............................................... II
Codeine (9050)............................................... II
Dihydrocodeine (9120)........................................ II
Oxycodone (9143)............................................. II
Hydromorphone (9150)......................................... II
Ecgonine (9180).............................................. II
Hydrocodone (9193)........................................... II
Meperidine (9230)............................................ II
Metazocine (9240)............................................ II
Dextropropoxyphene, bulk (non-dosage forms) (9273)........... II
Morphine (9300).............................................. II
Oripavine (9330)............................................. II
Thebaine (9333).............................................. II
Oxymorphone (9652)........................................... II
Phenazocine (9715)........................................... II
Fentanyl (9801).............................................. II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substances as radiolabeled compounds for biochemical
research.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
American Radiolabeled Chemical, Inc. to manufacture the listed basic
classes of controlled substances is consistent with the public interest
at this time. DEA has investigated American Radiolabeled Chemical Inc.
to ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the
company's physical security systems, verification of the company's
compliance with state and local laws, and a review of the company's
background and history. Therefore, pursuant to 21 U.S.C. 823, and in
accordance with 21 CFR 1301.33, the above named company is granted
registration as a bulk manufacturer of the basic classes of controlled
substances listed.
Dated: February 24, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-4403 Filed 3-2-10; 8:45 am]
BILLING CODE 4410-09-P